CAR-T cell therapy has transformed the treatment landscape for B-cell malignancies, but challenges like cost, scalability, safety, and accessibility remain. Emerging advancements in CAR-T technology aim to address these hurdles, improving patient outcomes and expanding access to care.
This guide delves into the latest innovations driving the next wave of CAR-T therapy, highlighting how these breakthroughs are poised to optimize clinical trial processes—from streamlined manufacturing to more efficient study execution.